Parchão, A.; Monteiro, C.; Araújo-Andrade, L.; Dias, C.C.; Abreu, C.
Herpes Zoster in Patients Treated with JAK Inhibitors for Immune-Mediated Inflammatory Diseases: Incidence, Associated Factors and Vaccination Uptake in a Real-World Cohort. J. Clin. Med. 2026, 15, 3733.
https://doi.org/10.3390/jcm15103733
AMA Style
Parchão A, Monteiro C, Araújo-Andrade L, Dias CC, Abreu C.
Herpes Zoster in Patients Treated with JAK Inhibitors for Immune-Mediated Inflammatory Diseases: Incidence, Associated Factors and Vaccination Uptake in a Real-World Cohort. Journal of Clinical Medicine. 2026; 15(10):3733.
https://doi.org/10.3390/jcm15103733
Chicago/Turabian Style
Parchão, António, Carolina Monteiro, Leonardo Araújo-Andrade, Cláudia Camila Dias, and Cândida Abreu.
2026. "Herpes Zoster in Patients Treated with JAK Inhibitors for Immune-Mediated Inflammatory Diseases: Incidence, Associated Factors and Vaccination Uptake in a Real-World Cohort" Journal of Clinical Medicine 15, no. 10: 3733.
https://doi.org/10.3390/jcm15103733
APA Style
Parchão, A., Monteiro, C., Araújo-Andrade, L., Dias, C. C., & Abreu, C.
(2026). Herpes Zoster in Patients Treated with JAK Inhibitors for Immune-Mediated Inflammatory Diseases: Incidence, Associated Factors and Vaccination Uptake in a Real-World Cohort. Journal of Clinical Medicine, 15(10), 3733.
https://doi.org/10.3390/jcm15103733
